Pda Technical Report 82
Utilizing specialized techniques, such as dilution or changes in pH, to break the masking effect before LAL testing.
One of the most critical aspects highlighted in TR 82 is the behavior of materials at extreme temperatures. Standard packaging configurations often fail when subjected to ultra-low environments. The Glass Transition Temperature ( Tgcap T sub g
PDA Technical Report No. 82 has fundamentally reshaped how the biopharmaceutical industry approaches endotoxin testing for complex biological products. By defining the phenomenon, outlining standardized study designs, and providing real-world case studies, it has converted a confusing analytical anomaly into a manageable, risk-based challenge. For any professional involved in the quality control of injectable biologics, PDA TR 82 is more than a recommendation—it is an essential guide for ensuring product safety and regulatory compliance. As the revision of this critical document progresses, it will continue to serve as the authoritative touchstone for one of modern pharmaceutical microbiology's most complex issues.
PDA Technical Report No. 82 was published in March 2019 as a 128-page PDF document with ISBN 9781945584077. As of this writing, PDA has announced a revision team is being assembled to update the document, ensuring its continued relevance as science and regulations evolve.
Low Endotoxin Recovery (LER) is a time- and temperature-dependent phenomenon where a known amount of bacterial endotoxin becomes undetectable over time when spiked into an undiluted drug product. First reported publicly by Chen and Vinther in 2013, LER specifically affects biologics and monoclonal antibodies. The Criteria for LER